Research Article: Efficacy and Safety of Anlotinib-Containing Regimens in Advanced Non-Small Cell Lung Cancer: A Real-World Study
Introduction:
Over the last decade, lung cancer has been the leading cause of cancer-related death among all malignancies. Lung cancer caused estimated . million new cases (.%) and . million deaths (%) in , as the second most commonly diagnosed cancer and the highest cancer-related mortality worldwide. Non-small cell lung cancer (NSCLC) accounts for approximately % of lung cancer cases and tends to be diagnosed at advanced stages, causing a huge mortality burden.
Read more